How are energy investors positioned?
MINNEAPOLIS—Jay Matushak, the Chief Financial Officer of NeueHealth, Inc. (NASDAQ:NEUE), a healthcare company with a market capitalization of approximately $59 million, has sold 472 shares of the company’s common stock, according to a recent SEC filing. InvestingPro analysis indicates the company is currently trading below its Fair Value. The sale, which took place on May 12, 2025, was executed at a weighted average price of $6.76 per share, totaling approximately $3,190.
These shares were sold to cover tax withholding obligations related to the vesting of restricted stock units, as noted in the filing. Following the transaction, Matushak retains ownership of 40,556 shares of NeueHealth stock. The shares were sold at prices ranging from $6.67 to $6.83 per share.
This transaction was not discretionary, aligning with the company’s compliance procedures. The company faces some financial challenges, with InvestingPro data showing negative EBITDA of $51.4 million in the last twelve months and revenue decline of approximately 18%.
In other recent news, NeueHealth Inc. reported its financial results for the first quarter of 2025, showcasing significant growth in its consumer base, with a 51% year-over-year increase, serving 709,000 consumers. Despite this growth, the company’s revenue slightly declined to $215.8 million compared to the previous year. However, NeueHealth maintained profitability, achieving an adjusted EBITDA of $13.5 million for the fifth consecutive quarter. The New Care segment contributed $90.5 million in revenue, while the New Solutions segment experienced a $3 million operating loss. Additionally, the company is planning to go private by mid-2025, a move led by an affiliate of one of its largest investors, NEA. Looking ahead, NeueHealth aims to expand its consumer base and deepen partnerships with payer groups. The company continues to participate in innovative government programs, serving approximately 41,000 consumers through initiatives like MSSP and ACO REACH. These developments reflect NeueHealth’s commitment to its consumer-centric care model and strategic growth initiatives.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.